| Peter Andre Gochee, MD | |
|
4880 Ne Goodview Cir, Lees Summit, MO 64064-1996 | |
| (816) 478-4200 | |
| (816) 875-2597 |
| Full Name | Peter Andre Gochee |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 4880 Ne Goodview Cir, Lees Summit, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124177712 | NPI | - | NPPES |
| 2500036327 | Other | MO | BNDD |
| 2009006306 | Other | MO | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2009006306 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cameron Regional Medical Center | Cameron, MO | Hospital |
| Bates County Memorial Hospital | Butler, MO | Hospital |
| Harrison County Community Hospital | Bethany, MO | Hospital |
| Excelsior Springs Hospital | Excelsior springs, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cameron Regional Medical Center Inc | 5092622001 | 58 |
| Bothwell Regional Health Center | 6103714126 | 92 |
| Bates County Memorial Hospital | 8123937356 | 27 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Excelsior Springs City Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285733923 PECOS PAC ID: 7315847209 Enrollment ID: O20040108000958 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Cameron Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811905375 PECOS PAC ID: 5092622001 Enrollment ID: O20040113000619 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Bates County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740311471 PECOS PAC ID: 8123937356 Enrollment ID: O20040121000624 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Bothwell Regional Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235102690 PECOS PAC ID: 6103714126 Enrollment ID: O20040310000246 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Carroll County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528067113 PECOS PAC ID: 2860485638 Enrollment ID: O20040407000120 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Saint Lukes Hospital Of Chillicothe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245433127 PECOS PAC ID: 0143130393 Enrollment ID: O20041014000548 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Entity Name | Harrison County Community Hospital District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528062569 PECOS PAC ID: 4587630926 Enrollment ID: O20071201000173 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Andre Gochee, MD 4860 College Blvd Ste 201, Overland Park, KS 66211-1681 Ph: (816) 478-4200 | Peter Andre Gochee, MD 4880 Ne Goodview Cir, Lees Summit, MO 64064-1996 Ph: (816) 478-4200 |
News Archive
Columbia Laboratories, Inc., and Watson Pharmaceuticals, Inc., today announced that Columbia has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PROCHIEVE® (progesterone gel) for the reduction of risk of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.
Kidney disease patients who are educated about dialysis are more likely to undergo a standard but under-utilized dialysis-related procedure than less knowledgeable patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
Leading politicians, officials, researchers and civil society organisations convened in Brussels at the launch of European Voice's multi-drug resistant (MDR-TB) policy report in the lead up to World TB day, to discuss the rising incidence of MDR-TB, the need for more effective treatments, new vaccines and better diagnostics and what needs to done at a European level to tackle this preventable disease.
University Hospitals Harrington Heart & Vascular Institute researchers Muhammad Panhwar, MD, and Mahazarin Ginwalla, MD, recently concluded a study of more than 22 million patients that suggests a strong connection between Inflammatory Bowel Disease (IBD) and the development of heart disease and heart attacks.
› Verified 3 days ago
Dr. Andrew Sinclair Pavlovich, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4880 Nw Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Dr. Colleen Nicole Johnson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Cir, Ste 340, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Dr. Daniel Adam Sleve, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Dr. Luke Jacob Dlabal Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3601 Ne Ralph Powell Rd, Suite C, Lees Summit, MO 64064 Phone: 816-347-1514 Fax: 816-347-1822 | |
Dr. Mark Owen Covington, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Cir, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-2597 | |
Dr. Kelvin L Walls, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Nw Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 |